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A 53-year-old man with a history of Hodgkin’s diseasetreated with mantle radiation 20 years ago presented with
right upper chest and upper arm pain. He was a current
smoker with a 30-pack year history. Chest computed tomog-
raphy showed a 3-cm mass in the right upper lobe medially
within the previous radiation port, with adjacent pleural
thickening and bilateral effusions (Figure 1). Bronchoscopic
biopsy of the mass showed grade 3 adenocarcinoma of the
lung (TTF-1 stain ). After bilateral thoracenteses were
cytologically negative, a positron emission tomographic scan
demonstrated uptake in the lesion, in the adjacent pleura, and
in an area near the tail of the pancreas (Figures 2 and 3).
Endoscopic ultrasound revealed a 16-mm lesion in the tail of
the pancreas, and subsequent biopsy revealed metastatic ad-
enocarcinoma from the lung (CK7, TTF-1, and CK20-),
establishing stage IV disease. The patient was started on
Gemzar and is currently stable and under treatment.
At time of diagnosis, clinically apparent metastasis to
the pancreas is infrequent; however, metastasis to the pan-
creas from the lung may be more common than appreciated.
A review of 2587 consecutive autopsies from 1973 to 1978
revealed that of 261 patients with metastatic disease in the
pancreas, the primary source was lung cancer in 49 (second
only to breast cancer; n  51).1 Another, more current,
autopsy review of 1740 cases from Japan examined 103 cases
of secondary pancreatic malignancies, 18 of which had
spread from the lung. This was second in frequency only to
stomach cancer (n  21).2 In 2004, an autopsy database from
Michigan showed the lung to be the greatest contributor of
pancreatic metastatic lesions, with 34 primary pulmonary
tumors in 81 cases of metastatic pancreatic disease (of
4955 total cases).3 The stomach was the second most
frequent source. Whereas metastatic lung disease to the
pancreas is uncommon, it should be considered in meta-
static work-ups and may be more frequently identified with
the use of preoperative positron emission tomographic
scans.
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FIGURE 1. Chest computed tomographic scan demonstrat-
ing right upper lobe mass.
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FIGURE 2. Positron emission tomographic image demon-
strating uptake in the tail of the pancreas.
FIGURE 3. Another view of a positron emission tomo-
graphic image demonstrating uptake in the tail of the pan-
creas.
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